PRE
Prenetics Global Ltd
22.90$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.0% | -4.2% | -4.2% | +1.1% | -9.4% | +0.0% | -6.8% | -1.3% | +3.6% | -13.9% | -12.3% | |
| – | -11.9% | +1.4% | -9.1% | -12.2% | +24.6% | +0.0% | +15.3% | -61.5% | +117.9% | +58.4% | +11.8% | |
| – | -77.5% | +240.7% | -24.4% | -22.5% | +63.6% | +0.0% | -67.0% | -23.1% | +142.2% | +74.3% | +5.4% | |
| – | -14.3% | -9.9% | -20.5% | -17.8% | – | – | -55.9% | -14.4% | +159.2% | +72.5% | +3.2% | |
| – | -9.2% | +137.0% | +61.0% | -26.9% | -55.2% | +6.9% | +78.7% | -82.1% | +66.5% | +298.2% | -56.8% | |
| – | -5.0% | -10.0% | +2.2% | +210.3% | -26.5% | +0.0% | -34.6% | +24.3% | +32.1% | +101.2% | -1.5% | |
| – | -13.7% | +0.0% | +0.0% | +28.1% | +0.0% | +0.0% | -78.1% | +0.0% | -83.2% | -100.0% | – | |
| – | -1.8% | -1.9% | -5.4% | -3.8% | -3.5% | +0.0% | +77.6% | -99.2% | +26,191.2% | -99.9% | -45.0% | |
| – | -7.6% | -7.2% | +3.6% | +31.6% | -24.1% | +0.0% | +14.2% | -26.8% | -17.8% | +87.1% | +11.9% | |
| – | -2.1% | -5.7% | +2.9% | +28.8% | -25.9% | +0.0% | +26.0% | -45.1% | +9.5% | -7.3% | +42.6% | |
| – | +634.8% | -93.3% | +9.6% | +140.9% | – | – | -44.7% | -6.6% | -6.7% | -69.4% | +32.2% | |
| – | -52.4% | -2.0% | +3.4% | +416.1% | -58.0% | +0.0% | +35.2% | +19.4% | +30.5% | -74.6% | -47.5% | |
| – | -8.1% | -3.4% | -5.6% | -5.1% | -4.6% | +0.0% | -11.4% | +6.8% | +8.3% | -30.6% | -23.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.2% | +0.8% | +0.1% | +4.1% | +1.0% | -1.1% | +4.3% | +4.9% | +15.4% | +5.9% | +1.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.